February 23, 2017

Ongoing Collaboration Aims to Accelerate Biosimilar Approval in China

Working with a service provider is one strategy that biosimilar manufacturers can pursue to facilitate speed to market. Implementing single-use technology is another. Pfizer, Inc. was looking for a company who could do both. To help them achieve regulatory approval for two biosimilar mAbs in China, Pfizer initiated a collaboration with GE’s Fast Trak services.

Through an ongoing collaboration with GE, Pfizer is continuing to benefit from the support of a global service and technology provider.

View Presentation